Loading clinical trials...
Loading clinical trials...
Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache: A Randomized Clinical Trial
The aim is to investigate whether opening of ATP-sensitive potassium (KATP) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Danish Headache Center
Copenhagen, Denmark
Start Date
March 21, 2022
Primary Completion Date
July 7, 2022
Completion Date
July 7, 2022
Last Updated
July 8, 2022
21
ACTUAL participants
Levcromakalim
DRUG
Placebo
DRUG
Lead Sponsor
Danish Headache Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01856270